These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 21913486)
41. Some malignant tumours in HIV -infected individuals in Benin City Nigeria. Osime OC; Onunu AN Niger Postgrad Med J; 2007 Sep; 14(3):195-8. PubMed ID: 17767201 [TBL] [Abstract][Full Text] [Related]
42. HIV and cancer: a comparative retrospective study of Brazilian and U.S. clinical cohorts. Castilho JL; Luz PM; Shepherd BE; Turner M; Ribeiro SR; Bebawy SS; Netto JS; McGowan CC; Veloso VG; Engels EA; Sterling TR; Grinsztejn B Infect Agent Cancer; 2015; 10():4. PubMed ID: 25685180 [TBL] [Abstract][Full Text] [Related]
43. Less cancer--or more--with HAART? Or, reflections on a late opus. Mascolini M J Int Assoc Physicians AIDS Care; 1998 Jun; 4(6):12-22. PubMed ID: 11365531 [TBL] [Abstract][Full Text] [Related]
44. Cancer in HIV-infected persons from the Caribbean, Central and South America. Fink VI; Shepherd BE; Cesar C; Krolewiecki A; Wehbe F; Cortés CP; Crabtree-Ramírez B; Padgett D; Shafaee M; Schechter M; Gotuzzo E; Bacon M; McGowan C; Cahn P; Masys D; J Acquir Immune Defic Syndr; 2011 Apr; 56(5):467-73. PubMed ID: 21239992 [TBL] [Abstract][Full Text] [Related]
45. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. Lyter DW; Bryant J; Thackeray R; Rinaldo CR; Kingsley LA J Clin Oncol; 1995 Oct; 13(10):2540-6. PubMed ID: 7595705 [TBL] [Abstract][Full Text] [Related]
46. Therapeutic approaches to AIDS-related malignancies. Berretta M; Cinelli R; Martellotta F; Spina M; Vaccher E; Tirelli U Oncogene; 2003 Sep; 22(42):6646-59. PubMed ID: 14528290 [TBL] [Abstract][Full Text] [Related]
47. Malignancies in HIV: the Indian scenario. Dhir AA; Sawant SP Curr Opin Oncol; 2008 Sep; 20(5):517-21. PubMed ID: 19106653 [TBL] [Abstract][Full Text] [Related]
48. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review. Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086 [TBL] [Abstract][Full Text] [Related]
49. Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico. Cornejo-Juárez P; Cavildo-Jerónimo D; Volkow-Fernández P AIDS Res Ther; 2018 Oct; 15(1):16. PubMed ID: 30368240 [TBL] [Abstract][Full Text] [Related]
50. Characterization of HIV-associated Hodgkin's lymphoma in HIV-infected patients: a single-center experience. Ruiz M; Parsons C; Cole J J Int Assoc Physicians AIDS Care (Chic); 2012; 11(4):234-8. PubMed ID: 22302202 [TBL] [Abstract][Full Text] [Related]
51. Incidence and risk factors of AIDS-defining cancers in a cohort of HIV-positive adults: Importance of the definition of incident cases. Suárez-García I; Jarrín I; Iribarren JA; López-Cortés LF; Lacruz-Rodrigo J; Masiá M; Gómez-Sirvent JL; Hernández-Quero J; Vidal F; Alejos-Ferreras B; Moreno S; Del Amo J Enferm Infecc Microbiol Clin; 2013 May; 31(5):304-12. PubMed ID: 22608566 [TBL] [Abstract][Full Text] [Related]
52. Cancer in HIV patients. Labarga P AIDS Rev; 2013; 15(4):237-8. PubMed ID: 24322384 [TBL] [Abstract][Full Text] [Related]
53. High Cancer Burden Among Antiretroviral Therapy Users in Malawi: A Record Linkage Study of Observational Human Immunodeficiency Virus Cohorts and Cancer Registry Data. Horner MJ; Chasimpha S; Spoerri A; Edwards J; Bohlius J; Tweya H; Tembo P; Nkhambule F; Phiri EM; Miller WC; Malisita K; Phiri S; Dzamalala C; Olshan AF; Gopal S Clin Infect Dis; 2019 Aug; 69(5):829-835. PubMed ID: 30452634 [TBL] [Abstract][Full Text] [Related]
54. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)]. Tserenpuntsag B; Kołacińska A; Jabłonowska E Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390 [TBL] [Abstract][Full Text] [Related]
55. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy. Mukhtar F; Ilozumba M; Utuama O; Cimenler O JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714 [TBL] [Abstract][Full Text] [Related]
56. The growing problem of non-AIDS-defining malignancies in HIV. Pantanowitz L; Schlecht HP; Dezube BJ Curr Opin Oncol; 2006 Sep; 18(5):469-78. PubMed ID: 16894295 [TBL] [Abstract][Full Text] [Related]
57. Epidemiological trends and therapeutic challenges of malignancies in adult HIV-1-infected patients receiving combination antiretroviral therapy in a tertiary hospital from Romania: An observational retrospective study. Gheorghiță V; Conea IF; Radu AMC; Ștefan I; Mărdărescu M; Petrea S; Streinu-Cercel A J Infect Public Health; 2019; 12(2):182-189. PubMed ID: 30344102 [TBL] [Abstract][Full Text] [Related]
58. Study of 172 Cases of AIDS Associated Cancers. Phatak UA; Gosavi VS; Chitale PV J Assoc Physicians India; 2022 Jan; 70(1):11-12. PubMed ID: 35062808 [TBL] [Abstract][Full Text] [Related]
59. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B; AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345 [TBL] [Abstract][Full Text] [Related]
60. Prevalence and mortality of cancer among people living with HIV and AIDS patients: a large cohort study in Turkey. Aydin OA; Gunduz A; Sargin F; Mete B; Karaosmanoglu HK; Sevgi DY; Yemisen M; Durdu B; Dokmetas I; Tabak F; East Mediterr Health J; 2020 Mar; 26(3):276-282. PubMed ID: 32281636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]